Is it the right time to introduce the hepatitis B booster vaccine in national immunization schedule? An analysis from the available evidence

• Hoofdauteurs: Sudip Bhattacharya (Auteur), Ozden Gokdemir (Auteur), Md Abu Bashar (Auteur), Arulmani Thiyagarajan (Auteur), Amarjeet Singh (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Hepatitis B virus (HBV) infection is a global health concern, and it is considered one of the deadliest infections in the world, having nearly 1.2 million deaths annually. Around 75% of all global HBV carriers live in the Asia-Pacific region. In this regard, India has a prevalence ranging between 2%...